1Small PK, Loudon MA, Hua CM, et al. Large - scale ambulatory study of postprandial jejunal in irritable bowel syndrome[J]. Scand J Gastroentered, 1997,32 ( 1 ): 39,
3Neal KR, Hebden J, Spiller R. Prevalence of gastrointestinal symptoms six months after bacterial gastroenteritis and risk factors for development of the irritable bowel syndrome: post survey of patients. BMJ, 1997, 314: 779-781.
4Drossman DA,Thompson WG, Talley NJ, et al. Identification of sub-groups of functional gastrointestinal disorders. Gastroenterol Int, 1990, 3:159-172.
5Jobin C , Gauthier J. Differential effects of cell density on 5-lipoxygenase, 5-lipooxygenase-activating protein and interleukin-1beta expression in human neutrophils. Infla mmation, 1997, 21:235-250.
7Swain MG, Blennerhassett PA, Collins SM. Impaired sympathetic nerve function in the inflamed rat intestine. Gastroenterology,1991,100:675-682.
8Kubota Y, Petras RE, Ottaway CA, et al. Colonic vasoactive intestinal peptide nerves in infla mmatory bowel disease. Gastroenterology, 1992,102:1242-1251.
9Gwee KA, Collins SM, Marshall JS, et al. Evidence of infla mmatory pathogenesis in post- infectious irritable bowel syndrome. Gastroenterology, 1998,114:A930.
10Collins SM. Irritable bowel syndrome could be an infla mmatory disorder. Eur J Gastroenterol Hepatol, 1994,6:478-483.
